注射用丹参多酚酸盐的临床应用分析

目的：分析注射用丹参多酚酸盐的临床应用情况，探讨药物的合理应用。方法：采用Excel表对使用丹参多酚酸盐注射液的1000份病历进行统计分析。主要项目包括：患者一般情况、疾病诊断、用药科室、用药剂量、疗程、溶媒的选择及联合用药、药品不良反应等。结果：1000份病历中，丹参多酚酸盐注射液临床用于冠心病心绞痛的只有78例（7．8％），而用于颈椎病高达188例（18．8％），脑梗死及后遗症为155例（15．5％），高血压为73例（7．3％），腰椎病为105例（10．5％）。用药剂量合格率15．9％，疗程合格率14．3％，丹参多酚酸盐注射液在适应讧、用药剂量、溶媒和联合用药等方面均存在不合理现象。结论：注射用丹参多酚酸盐存在不合理用药现象，应严格按说明书用药，保证临床用药安全。

Analysis of the Clinical Use of Salvianolate Injection

Objective：To analyze the clinical use of salvianolate injection and discuss the rational use of drugs. Methods： 1000 cases of salvianolate injection were reviewed and the data mainly including their general condition, disease diagnosis, departments using the drugs, drug dose, course of treatment, choice of solvent, drug combination, occurenee of ADRS, etc. were analyzed with Excel. Results：In 1000 cases,the percentages of the clinical application of salvianolate for the coronary heart disease were 7.8% （78 cases） , 18.8% （ 188 cases） for cervical spondylosis,15.5% （ 155 cases） for in- farction and sequelae,7.3% （73 cases） for hypertension and 10.5% （ 105 cases） for lumbar spondylosis. The passing rate of the drug dose was 15.9% （ 159 cases）. The qualified rate of drug treatment was 14.3% （ 143 cases）. In the clinical ap- plication of salvianolate injection, a high rate of unreasonable usage was found in indication, dosage, solvent dispensing and drug combination. Conclusion： BeCause the problems still existed in the use of salvianolate injection, drugs should be strictly used according to drug instructions to reduce drug risks and strengthen the guidance of rational drug use.